XTL Biopharmaceuticals Ltd. (TASE:XTLB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kenneth J Zuerblis Other companies: Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 10, 2020 · Past); Savient Pharmaceuticals Inc (EVP, Chief Financial Officer · Sep 12, 2011 – Feb 1, 2012 · Past); Immunomedics Inc (Director · Feb 9, 2010 – Dec 7, 2011 · Past) | Director · Oct 10, 2008 – Oct 10, 2008 · Past |
| William James Kennedy Other companies: TG Therapeutics, Inc. (Director · Apr 16, 2012 – Jun 17, 2020 · Past) | Director · Nov 4, 2008 – Nov 4, 2008 · Past |
| Dobroslav Melamed | Director · Since at least Nov 6, 2026 |
| Doron Turgeman | Chief Executive Officer · Since at least Nov 6, 2026 |
| Fain Osnat Hillel | Director · Since at least Mar 18, 2026 |
| Iris Shapira Yalon | Director · Since at least Nov 6, 2026 |
| Itay Weinstein | Chief Financial Officer · Since at least Nov 6, 2026 |
| Jonathan Schapiro | Director · Since at least Nov 6, 2026 |
| Joshua Levine | Chief Executive Officer · Since at least Nov 6, 2026 |
| Noam Band | Chief Executive Officer · Apr 7, 2025 – Nov 6, 2026 · Past |
| Ossi Hillel Fain | Director · Since at least Nov 6, 2026 |
| Samuel Rudman | Director · Oct 10, 2008 – Oct 10, 2008 · Past |
| Shlomo Shalev | Chief Executive Officer · Since at least Apr 7, 2025 |
| William Kessler | Director of Finance · Aug 21, 2007 – Aug 21, 2007 · Past |